PHARMACY AND PHARMACOLOGY JOURNAL

Dr. Barakat is at the forefront of pioneering research aimed at developing innovative immunotherapy drugs targeting immune checkpoint proteins. As the leader of a distinguished multidisciplinary research team, he spearheads groundbreaking efforts in this crucial area of medical science.

With a Ph.D. in biophysics earned from the University of Alberta in 2012, Dr. Barakat brings a wealth of expertise to his role. Following his doctoral studies, he completed a prestigious postdoctoral fellowship in Professor Michael Houghton’s Lab, further honing his skills and knowledge in the field.

Throughout his illustrious career, Dr. Barakat has garnered numerous accolades and honors, including coveted fellowships from CIHR and AIHS, as well as recognition such as the UofA dissertation award, ACRI Studentship, and various distinction awards during his academic journey.

In addition to his research endeavors, Dr. Barakat serves as an editor for several esteemed scientific journals, contributing to the advancement of knowledge in his field. His lab receives support from esteemed funding agencies, including the Alberta Cancer Foundation, Li Ka Shing Applied Virology Institute, Natural Sciences and Engineering Research Council (NSERC), Li Ka Shing Institute of Virology, and IC-IMPACTS Centres of Excellence.

Through his groundbreaking research and leadership, Dr. Barakat is paving the way for new and improved immunotherapy treatments, offering hope to patients and transforming the landscape of cancer treatment and beyond.